chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.48
Sex: F
Vaccine: DTAP
Symptoms: Pyrexia, Vomiting
Clinical narrative: DAPTACEL #4 given in R UT on 2/5/16. Mom paged Dr. on Saturday due to fever (101)-(100) and vomiting. Denies Redness at injection site. Fever down to 99 today with no fever reducer.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Pain, Skin burning sensation
Clinical narrative: 2/4/16 - Tdap given at approximately 1100. 2/5/16 - Sx onset at 1730. Body aches, swelling, redness at injection site. Skin felt "on fire". 2/8/16 - Cool compresses, Loratadine 10mg QD and Famotidine 20mg BID and topical steroid cream.
Age: 83.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site rash, Pain in extremity, X-ray limb normal
Clinical narrative: (L) arm pain and rash on site.
Age: 62.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site inflammation, Injection site pain, Injection site warmth
Clinical narrative: Pain and inflammation with warm area at injection site; site is 4" x 4" red, patient has taken TYLENOL, ice, and lavender oil.
Age: 69.0
Sex: M
Vaccine: PPV
Symptoms: Pain, Swelling
Clinical narrative: Pt noted swelling and severe pain beginning several hrs after shot. By evening, was painful to lift arm to remove shirt. Next day was 50% better. On 3rd day was 50% more better. So within 48 hours pt was about 85% better. As of 2-18-16 pt is completely recovered.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 10-NOV-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L030587, expiry date: 10-FEB-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to an unspecified number of patients. The patient's medical histories and concurrent conditions were not provided. On an unknown date in January 2016, the unspecified number of patients were vaccinated with ROTATEQ (lot # L013202, expiration date 27-JAN-2017, oral)(dose number, frequency and concentration were not reported). It was reported that the vaccines administered were improperly stored at 47.1 F for a time frame of 5 minutes and 45 seconds. No product quality complaint (PQC) was reported. This is one of two reports from the same source. Additional information has been requested.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient has developed shingles on her forehead and near her eye.
Age: 80.0
Sex: F
Vaccine: PNC13
Symptoms: Computerised tomogram, Gait disturbance, Nuclear magnetic resonance imaging, Pain in extremity, Walking aid user
Clinical narrative: Took PREVNAR 13 at 11:00 am and about 3:30 pm got excruciating pain in right leg, unable to walk normally. As of this date have to use cane to walk. MRI, Cat Scan, X-Ray have been taken.
Age: 80.0
Sex: F
Vaccine: PNC13
Symptoms: X-ray
Clinical narrative: Took PREVNAR 13 at 11:00 am and about 3:30 pm got excruciating pain in right leg, unable to walk normally. As of this date have to use cane to walk. MRI, Cat Scan, X-Ray have been taken.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 19.0
Sex: M
Vaccine: HEPA, MENB
Symptoms: Chills, Diarrhoea, Nausea, Vomiting
Clinical narrative: Had TRUMENBA and Hep A Friday at 10:30AM. Friday night began vomiting at 10PM vomited x3; diarrhea began at 10PM and 2-3 episodes Fri PM, Sat and Sun. Today (Monday) no vomiting/diarrhea but nauseous. Chilled; no temp. No meds or treatment. Was treated - still taking meds for a UTI dx 01/28/16.
Sex: U
Vaccine: VARZOS
Symptoms: In vitro fertilisation
Clinical narrative: This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patient's pertinent medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # L035283, expiry date 15-DEC-2016, dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX underwent temperature excursion (14.7 F for 2 hours and 15 minutes). There were no previous temperature excursions. This is one of several reports from the same reporter. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: Pt received PNEUMOVAX on 1/28/2016. On 01/29/2016 pt called complaining of severe pain and soreness at site of injection. Pt later came in store to show sore arm. There were no signs of bruising. No redness or breaking out. Pt then went to her PCP on the afternoon of 1/29/16. I called pt next day - MD told her to work out the soreness and gave her a steroid shot. Dr told pt. she should be better in 4-5 days.
Age: 39.0
Sex: M
Vaccine: PPV
Symptoms: Cellulitis, Injection site swelling, Local swelling, Pain in extremity, Peripheral swelling
Clinical narrative: Patient received PCV23 at 1:20 PM on 1/22/2016. At 4PM on 1/22/216, patient developed swelling at the injection site/arm (left arm) from the left elbow to left side of the neck. MD on call was notified, MD ordered ice applied to the left arm. On 1/23/2016 at 4PM, pt. developed a low grade fever of 99 degrees, the left arm continued to be swollen, painful and warm to touch. MD on call notified, patient ordered to be sent to local ER for evaluation. Patient diagnosed with cellulitis, KEFLEX ordered.
Age: 39.0
Sex: M
Vaccine: PPV
Symptoms: Pyrexia, Skin warm, White blood cell count increased
Clinical narrative: Patient received PCV23 at 1:20 PM on 1/22/2016. At 4PM on 1/22/216, patient developed swelling at the injection site/arm (left arm) from the left elbow to left side of the neck. MD on call was notified, MD ordered ice applied to the left arm. On 1/23/2016 at 4PM, pt. developed a low grade fever of 99 degrees, the left arm continued to be swollen, painful and warm to touch. MD on call notified, patient ordered to be sent to local ER for evaluation. Patient diagnosed with cellulitis, KEFLEX ordered.
Age: 73.0
Sex: F
Vaccine: PNC13
Symptoms: Body temperature decreased, Pneumonia
Clinical narrative: She was diagnosed with pneumonia after receiving PREVNAR 13. Already finished two antibiotics, still not better. Also complain about lower body temp.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a nurse refers to an unknown number of patients of unknown age and gender. No concurrent condition or medical history were reported. On an unknown date the patients were vaccinated with improperly stored (temp. 12 degree Celsius, time 6 hours) ROTATEQ (lot # L010126, xp. 22-JAN-2017, dose and route of administration not provided). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from the same reporter link. Additional information is not expected since the reporter did not wish further contact.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: On 01/22/2016 patient presented with a vesicular rash on the right thigh, it "spread: to the back (right side) to the right knee consistent with shingles.
Age: 0.34
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Chest X-ray normal, Pyrexia
Clinical narrative: -Fever. -Amoxicillin
Age: 12.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Chest pain, Feeling abnormal, Limb discomfort, Oral pruritus, Swollen tongue
Clinical narrative: ? Reaction to MENACTRA - started with symptoms per mom '10 minutes after leaving office. Symptoms included "weird feeling", arm felt heavy, tongue swelling. mouth itching, chest pains. Instructed  mom to given BENADRYL and call 911 for transport to nearest ER. I was already home when she called off back. ER gave prednisone, famotidine,  and cetirizine. Epipen prescribed.
Age: 12.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Oral pruritus, Pruritus, Swollen tongue
Clinical narrative: ? Reaction to MENACTRA - started with symptoms per mom '10 minutes after leaving office. Symptoms included "weird feeling", arm felt heavy, tongue swelling. mouth itching, chest pains. Instructed  mom to given BENADRYL and call 911 for transport to nearest ER. I was already home when she called off back. ER gave prednisone, famotidine,  and cetirizine. Epipen prescribed.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Red, swollen, and itchy at site of injection.
Age: 0.51
Sex: M
Vaccine: DTAP, HIBV, IPV, PPV
Symptoms: Urticaria
Clinical narrative: Infant developed generalized urticarial 24 hours after vaccinations. Lesions resolved with 3 doses of fexofenadine.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 31-JAN-2016, the patient was vaccinated with improperly stored (temperature: 17 F, time frame: 15 hours) dose of VARIVAX (Merck) lot # L0103827, expiry date: 21-APR-2017 (dose, site and route of administration were not reported). No symptoms were reported. Additional information has been requested.
Age: 0.54
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Lipoma, Local reaction, Supportive care
Clinical narrative: Left thigh with lipoma, local reaction after immunizations. Rx: supportive care.
Age: 43.0
Sex: F
Vaccine: HEP, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: In area of injection on right deltoid, warm to touch, red and swollen. Referred to PMD.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage
Clinical narrative: This spontaneous report as received from a licensed practical nurse referring to an unspecified number of patients. The patient's medical histories and concurrent conditions were not provided. On an unknown date in JANUARY 2016, the unspecified number of patients were vaccinated with LIQUID PEDVAXHIB (lot # L030870, expiration date 18-JUN-2018)(route, dose number, frequency and concentration were not reported). It was reported that the vaccines administered were improperly stored at 47.1 F for a time frame of 5 minutes and 45 seconds. No product quality complaint (PQC) was reported. This is one of two reports from the same source. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: HEP, PNC13, VARCEL
Symptoms: Erythema, Local swelling, Pain, Pruritus
Clinical narrative: Quarter sized, raised red bump, sore to touch, itchy. Writer referred ct to her PCP.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-NOV-2015, the patient was vaccinated with improperly stored PROQUAD with lot number: L030587, expiry date: 10-FEB-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC). No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 1.22
Sex: F
Vaccine: PNC13
Symptoms: Abasia, Crying
Clinical narrative: Child was given vaccine and had three days of inconsolable crying along with inability to walk for two days.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 30-SEP-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 07-DEC-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 02-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 69 year old female patient. The patient had no drug reactions/allergies. There was  no information about patient's concomitant medications and pertinent medical history reported. On 08-DEC-2015, the patient was vaccinated with a dose of PNEUMOVAX23, injection, lot # L029113, expiry date: March 2017, intramuscularly (dose was not reported). Since having the vaccination on 08-DEC-2015, the patient experienced "constant pain at the injection site". There  was no treatment given for the event. No lab diagnostics studies were performed. The outcome of the event was reported as not recovered/not resolved. The patient sought medical attention by calling the pharmacist. The relatedness between the event and PNEUMOVAX23 was not reported. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 29-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 26-AUG-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. No medical history or concurrent conditions were reported. On 21-OCT-2015, and then on 16-DEC-2015, the patient was vaccinated with RECOMBIVAX HB (dose and route and lot number were not provided). Concomitant medication was not reported. No adverse symptoms were reported and there was not product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 15-OCT-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 27-AUG-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 12-NOV-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L030587, expiry date: 10-FEB-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 11-SEP-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 06-OCT-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were  reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 21-OCT-2015, the patient was vaccinated with improperly stored (Oka/Merck) PROQUAD with lot number: L0026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 18-NOV-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 21-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patients'  pertinent medical history, concurrent conditions, concomitant therapies, drug reaction or allergies were not reported. The reporter stated that, since 11-JAN-2016, the patients were vaccinated with doses of ROTATEQ, oral liquid, lot # L013203, expiration date 28-JAN-2017 (dose and dose number were unspecified), that were exposed to 47.9F during 5 minutes. No adverse experience has been reported. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reaction or allergies were not reported. The reporter stated that, since 11-JAN-2016, the patients were vaccinated with doses of PNEUMOVAX23, lot # L019835, expiration date 23-MAR-2017 (dose, dose number, route, and anatomical location were unspecified) that were exposes to 47.9F during 5 minutes. No adverse experience has been reported. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reaction or allergies were not reported. The reporter stated that, since 11-JAN-2016, the patients were vaccinated with doses of GARDASIL, lot # K011325, expiration date 08-APR-2017 (dose, dose  number, route and anatomical location were unspecified), that were exposed to 47.9 F during 5 minutes. No adverse experience has been reported.  This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This spontaneous report was received from a physician via company representative and refers to a patients of unknown age and gender, described in the article entitle "Shingles Vaccine May Pose Eye risk in some people". There was no information about patient's pertinent medical histories, concomitant medications, drug reactions or allergies provided. On an unknown dates, the patients were vaccinated with ZOSTAVAX injection (lot #, expiration date, dose, anatomical location and route of administration were not reported). On an unknown dates, the patients experienced a shingles flare-up. The outcome of the event was unknown. The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to 6 unspecified patients of unknown gender and age. Information regarding patients' medical history, concurrent condition drug reactions/allergies and concomitant therapy was not provided. On unspecified dates, these patients were vaccinated with an improperly stored dose of (Oka/Merck) PROQUAD (lot # L041627, expiry date: 20-APR-2017). Reporting nurse stated that the mentioned vaccine was out of range for a total time frame of 198 hours and a maximum temperature reached was 0 degree Celsius. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information is not expected as the reporter did not wish further contact.
Sex: U
Vaccine: VARZOS
Symptoms: Keratitis
Clinical narrative: This spontaneous report was received from a physician via company representative and refers to a adult patients of unknown age and gender, described in the article entitled "Shingles Vaccine May Pose Eye risk in some people".  There was no information about patient's pertinent medical histories, concomitant medications, drug reactions or allergies provided. On an unknown dates, the adult patients were vaccinated with ZOSTAVAX injection (lot#, expiration date, dose, anatomical location and route of administration were not reported). On an unknown dates, within 24 hours after vaccination, the patients experienced keratitis, which had been linked to autoimmune disorder or inflammation of the clear layer on the front of the eye. The events could cause serious complications or event permanent damage to vision, if was left untreated. The outcome of the events was unknown. The reporter considered the events to be probable related to ZOSTAVAX. However, the new study was not designed to prove that the vaccine caused that condition. This is one of several reported received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history or drug allergies/drug reactions were not reported. On 03-FEB-2016, the patient was vaccinated with an expired dose of ZOSTAVAX (lot # K019388, expiration date 20-FEB-2016) (route, strength and anatomical location were not specified). There was no concomitant medication reported. No adverse effect was reported and no product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant concerning an unspecified number of patient of unknown age and gender. The patients' pertinent medical history, concurrent conditions, concomitant therapies, drug reaction or allergies were not reported. The reporter stated that, since 11-JAN-2016, the patients were vaccinated with doses of M-M-R II, lot # L012482, expiration date 10-APR-2017 (dose, dose number, route, and anatomical location were unspecified) that were exposes to 47.9F during 5 minutes. No adverse experience has been reported. This is one of several cases received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Eye inflammation, Keratitis
Clinical narrative: This spontaneous report was received from a physician via company representative and refers to a child patients of unknown exact age and gender described in the article entitled "Shingles Vaccine May Post Eye risk in some people". There was no information about patient's pertinent medical histories, concomitant medications, drug reactions or allergies provided.  On an unknown dates, the child patients were vaccinated with (Oka/Merck) VARIVAX (lot #, expiration date, strength, dose, anatomical location and route of administration were not reported). On an unknown dates, within 14 days after the vaccination, the patients experienced keratitis or inflammation of the clear layer on the front of the eye. The events could cause serious complications or event permanent damage to vision, if it was left untreated. The outcome of the events was unknown. The reporter considered the events to be probable related to (Oka/Merck) VARIVAX. However, the new study was not designed to prove that the vaccine caused that condition. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 17-SEP-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist and refers to an unspecified number of patients of unknown age and gender. There was no information about patients' pertinent medical histories, concomitant medications, drug reactions or allergies provided. On an unknown dates, the patients were vaccinated with an improperly stored doses of (Oka/Merck) VARIVAX (lot #, expiration date, dose, anatomical location and route of administration were not reported). No adverse effects were reported. Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist and refers to a 28 year old female patient. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 04-FEB-20156, the patient was vaccinated with an expired dose of M-M-R II (lot # J011332, expiration date 19-SEP-2015 (dose and route of administration were not reported). No adverse effects reported. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 09-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 02-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K0102155, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 11-SEP-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 26-AUG-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 02-OCT-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L026728, expiry date: 15-JAN-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent  condition, medical history or allergy/drug reactions were reported. On 21-AUG-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 27-AUG-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 26-AUG-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter.
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse referring to a 12 year old male patient. The patient's  concurrent conditions and medical history were not provided. On 22-JAN-2016, the patient was vaccinated with a first dose of GARDASIL 9, lot # L014415, expiration date on 25-JUL-2017 (route was not provided. Then; at the same day, the patient went to another clinic and was vaccinated with a second dose of GARDASIL 9 (route, lot number and expiration date were unspecified). Concomitant therapies were not provided. No adverse events were reported. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 10-SEP-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On unknown dates (reported as before today, 04-FEB-2016), the patient received an unspecified number of doses of ROTARIX (strength, dose, dose number, interval and route of administration were not reported). On 04-FEB-2016, the patient was vaccinated with a dose of ROTATEQ oral (exact dose, lot # and expiration date were not reported). There were no concomitant medications provided. There were no adverse effects reported. The outcome of the event was unknown. The causality assessment was not provided. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 04-SEP-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 30-SEP-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K010215, expiry date: 05-MAY-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concomitant condition, medical history or allergy/drug reactions were reported. On 26-AUG-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 09-SEP-2015, the patient was vaccinated with improperly stored PROQUAD (Merck) with lot number: L007230, expiry date: 03-SEP-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 11-DEC-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-AUG-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date:08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.